Banco Santander, S.A. Eli Lilly & CO Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

A detailed history of Banco Santander, S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Banco Santander, S.A. holds 74,447 shares of LLY stock, worth $56.9 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

74,447

Previous 76,369 2.52%

Holding current value

$56.9 Million

Previous $69.1 Million 4.61%

% of portfolio

0.78%

Previous 0.86%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $1.48 Million - $1.85 Million	-1,922 Reduced 2.52%	74,447 $66 Million
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $2.14 Million - $2.69 Million	2,954 Added 4.02%	76,369 $69.1 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $4.74 Million - $6.34 Million	7,996 Added 12.22%	73,415 $57.1 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $137,074 - $161,592	261 Added 0.4%	65,419 $38.1 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $6.37 Million - $8.79 Million	14,660 Added 29.03%	65,158 $35 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $2.77 Million - $3.7 Million	7,888 Added 18.51%	50,498 $23.7 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $3.78 Million - $4.43 Million	12,156 Added 39.92%	42,610 $14.6 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $1.25 Million - $1.45 Million	-3,883 Reduced 11.31%	30,454 $11.1 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $94,280 - $107,442	-318 Reduced 0.92%	34,337 $11.1 Million
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $5.76 Million - $6.77 Million	20,683 Added 148.03%	34,655 $11.2 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $590,010 - $733,233	2,514 Added 21.94%	13,972 $4 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $637,224 - $790,799	-2,834 Reduced 19.83%	11,458 $3.17 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $606,519 - $746,407	2,737 Added 23.69%	14,292 $3.3 Million
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $546,344 - $706,692	3,026 Added 35.48%	11,555 $2.65 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $56,361 - $72,962	343 Added 4.19%	8,529 $1.59 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $344,936 - $456,433	2,644 Added 47.71%	8,186 $1.38 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $479,894 - $555,084	3,282 Added 145.22%	5,542 $821,000
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $45,837 - $55,164	-336 Reduced 12.94%	2,260 $371,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $23,214 - $28,733	195 Added 8.12%	2,596 $360,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $2.28 Million - $2.48 Million	-21,350 Reduced 89.89%	2,401 $269,000
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $251,604 - $293,685	2,271 Added 10.57%	23,751 $2.63 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $13,134 - $15,460	-118 Reduced 0.55%	21,480 $2.76 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $2.88 Million - $3.23 Million	-27,199 Reduced 55.74%	21,598 $2.5 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $39,323 - $49,147	-458 Reduced 0.93%	48,797 $5.24 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $296,592 - $340,395	-3,918 Reduced 7.37%	49,255 $4.2 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $3.95 Million - $4.66 Million	53,173 New	53,173 $4.11 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Eli Lilly & CO Transaction History